Stereotaxis (STXS) Income from Continuing Operations (2010 - 2026)

Stereotaxis' (STXS) quarterly Income from Continuing Operations came in at 12778000.0 in Q1 2026, down 105.34% year-on-year from 239510524.1 in Q1 2025, and down 83.49% on a QoQ basis from 6964000.0 in Q4 2025.

Stereotaxis (STXS) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has 17 years of Income from Continuing Operations data on file, last reported at 12778000.0 in Q1 2026.

  • On a quarterly basis, Income from Continuing Operations fell 105.34% year-over-year to 12778000.0 in Q1 2026; TTM through Mar 2026 was 32458000.0, a 16.93% decrease from a year earlier, with the FY2025 full-year figure at 24312000.0, up 61.77% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 12778000.0, down from 6964000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for STXS reached as high as 4523000.0 in Q1 2022 and fell as low as 12778000.0 in Q1 2026.
  • Historically, Income from Continuing Operations has averaged 6350705.88 across 5 years, with a median of 5861000.0 in 2023.
  • Across the five-year window, Income from Continuing Operations slumped 109.5% in 2022 and gained 19.3% in 2025, its largest moves.
  • Year by year, Income from Continuing Operations stood at 4696000.0 in 2022, then retreated by 18.46% to 5563000.0 in 2023, then slumped by 55.13% to 8630000.0 in 2024, then grew by 19.3% to 6964000.0 in 2025, then plunged by 83.49% to 12778000.0 in 2026.
  • Per Business Quant data, the three most recent Income from Continuing Operations figures were 12778000.0 in Q1 2026, 6964000.0 in Q4 2025, and 6855000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 240.00 Mn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 823.20 Mn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -37.00 Mn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 239.00 Mn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 398.73 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 147.90 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -77.90 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 13.00 Mn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 112.77 Mn
10 Stereotaxis 136.49 Mn 121.87 Mn 3.79 Mn -12.78 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.78 Mn
Dec 31, 2025 -6.96 Mn
Sep 30, 2025 -6.86 Mn
Jun 30, 2025 -5.86 Mn
Mar 31, 2025 -6.22 Mn
Dec 31, 2024 -8.63 Mn
Sep 30, 2024 -6.63 Mn
Jun 30, 2024 -6.27 Mn
Mar 31, 2024 -5.00 Mn
Dec 31, 2023 -5.56 Mn
Sep 30, 2023 -5.89 Mn
Jun 30, 2023 -5.52 Mn
Mar 31, 2023 -5.86 Mn
Dec 31, 2022 -4.70 Mn
Sep 30, 2022 -5.28 Mn
Jun 30, 2022 -5.40 Mn
Mar 31, 2022 -4.52 Mn
Dec 31, 2021 -3.78 Mn
Sep 30, 2021 -5.24 Mn
Jun 30, 2021 -3.93 Mn